Psychedelics are going mainstream. Investing in them hasn't.

, January 8, 2024
Pharma

Drugs like LSD have shown potential for treating psychiatric disorders. Wall Street and big pharma aren't convinced.

Merck looks to join the obesity drug frenzy

, January 5, 2024
Pharma

Merck & Co. is seeking new obesity-fighting drugs called GLP-1s, joining a host of companies angling for a slice of the exploding market.

FDA issues first approval for mass drug imports to states from Canada

, January 5, 2024
Pharma

The agency authorized Florida to purchase medicines directly from wholesalers in Canada, where prices are far cheaper. Pharmaceutical companies oppose the plan.

FDA looking into reports of hair loss, suicidal thoughts in people using popular drugs for diabetes and weight loss

, January 4, 2024
Pharma

The FDA is evaluating reports of side effects such as hair loss and suicidal thoughts in people taking medications like Ozempic, Mounjaro and Wegovy.

Insulin $35 cap price now in effect, lowering costs for many Americans with diabetes

, January 4, 2024
Pharma

A price cap on insulin from one of the three major manufacturers took effect on New Year's Day, giving more Americans with diabetes more affordable treatments.

CVS will remove Humira from some drug reimbursement lists

, January 4, 2024
Pharma

CVS Health will remove AbbVie's blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of April 1, and will recommend biosimilar versions of the medicine instead.

Pages